Why Few Women Get Breast Cancer Test

A groundbreaking breast cancer test in the Netherlands, designed to determine if chemotherapy is truly needed, is being underutilized—only one-third of eligible women are getting it, despite it being fully covered by insurance. Before 2023, uptake was even lower, at just 10%. This means many patients may be enduring unnecessary chemo, raising serious concerns about patient care. Researchers are now investigating the barriers to adoption and working to close this critical gap in treatment decisions. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/0c9efb8165f0e6db